Predicted impact of vaccination against human papillomavirus 16|[sol]|18 on cancer incidence and cervical abnormalities in women aged 20|[ndash]|29 in the UK

摘要

Background:Human papillomavirus (HPV) vaccination has been approved in more than 90 countries and is being implemented in many of these. In the UK, vaccination for girls aged 12–13 with catch-up for girls up to age 18 was introduced in 2008, using the bivalent GSK vaccine (Cervarix).